SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-124889
Filing Date
2022-12-06
Accepted
2022-12-06 16:15:42
Documents
14
Period of Report
2022-12-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2232094d1_8k.htm   iXBRL 8-K 35725
2 EXHIBIT 3.1 tm2232094d1_ex3-1.htm EX-3.1 140516
3 EXHIBIT 10.1 tm2232094d1_ex10-1.htm EX-10.1 29389
  Complete submission text file 0001104659-22-124889.txt   425508

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ptct-20221205.xsd EX-101.SCH 3027
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptct-20221205_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptct-20221205_pre.xml EX-101.PRE 22591
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2232094d1_8k_htm.xml XML 3609
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 221447974
SIC: 2834 Pharmaceutical Preparations